A New Clue in Developmental Disorders
Bi-allelic mutations associated with intellectual disability and brain abnormalities
Clinical Scorecard: A New Clue in Developmental Disorders
At a Glance
Category Detail
Condition ASTN1-related neurodevelopmental disorders Key Mechanisms Bi-allelic variants in the ASTN1 gene disrupt neuronal migration during brain development. Target Population Individuals with unexplained neurodevelopmental disorders, particularly children. Care Setting Pediatric and neurological practice.
Key Highlights
ASTN1 gene variants linked to developmental delay and intellectual disability. Clinical features include autism spectrum disorder, ADHD, and epilepsy. Brain imaging shows variable results, from normal to significant abnormalities. Importance of comprehensive genomic testing for accurate diagnosis. Recognition of complex inheritance patterns in neurodevelopmental disorders. Guideline-Based Recommendations
Diagnosis
Consider comprehensive genomic testing for patients with unexplained neurodevelopmental disorders. Management
Provide genetic counseling and family risk assessment based on ASTN1 findings. Monitoring & Follow-up
Monitor developmental progress and associated clinical features in affected individuals. Risks
Potential for structural brain abnormalities and developmental impairment. Patient & Prescribing Data
Individuals with bi-allelic variants in the ASTN1 gene.
Management strategies should be tailored based on the spectrum of clinical features.
Clinical Best Practices
Utilize exome or genome sequencing to identify rare variants. Consider multilocus pathogenic variation in genetic assessments. Recognize the broad clinical spectrum associated with ASTN1-related disorders. Related Resources & Content
